Transient virus infection and multiple sclerosis

Reviews in Medical Virology

Volumn 10, Issue 5, 2000, Pages 291-303

  Atkins, G J ^a   McQuaid, S ^b   Morris Downes, M M ^a   Galbraith, S E ^a   Amor, S ^c   Cosby, S L ^b   Sheahan, B J ^d  

^a TRINITY COLLEGE DUBLIN   (Ireland)

^b ROYAL VICTORIA HOSPITAL   (United Kingdom)

^c CHARING CROSS HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE DUBLIN   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ALLERGIC ENCEPHALOMYELITIS; AUTOIMMUNITY; CELL DAMAGE; CORONAVIRUS; DATA ANALYSIS; DEMYELINATION; DISEASE COURSE; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; HEPADNAVIRUS; HYPOTHESIS; MULTIPLE SCLEROSIS; OLIGODENDROGLIA; ORTHOMYXOVIRUS; PAPOVAVIRUS; PATHOGENESIS; PICORNAVIRUS; RELAPSE; RETROVIRUS; REVIEW; RHABDOVIRUS; TOGAVIRUS; VIRUS INFECTION;

ANIMAL; DISEASE MODELS, ANIMAL; ENCEPHALOMYELITIS, EXPERIMENTAL AUTOIMMUNE; HUMAN; MULTIPLE SCLEROSIS; SUPPORT, NON-U.S. GOV'T; VIRUS DISEASES; VIRUSES;

EID: 0033807685     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-1654(200009/10)10:5<291::AID-RMV278>3.0.CO;2-U     Document Type: Review

References (98)

1. Multiple sclerosis and childhood infections
2. Serendipity and multiple sclerosis epidemiology
3. Is sporadic MS caused by an infection of adolescence and early childhood? A case-control study of birth order position
4. Further evidence in support of the hypothesis that one cause of multiple sclerosis is childhood infections
5. The evolution of multiple sclerosis epidemiology
6. Epidemiologic evidence for multiple sclerosis as an infection
7. Genetic factors in the pathogenesis of MS
8. Pathogenesis of multiple sclerosis - The immune diathesis and the role of viruses
9. Animal model systems of MS
10. Pathogenesis of virus induced demyelination
11. Pathogenesis of multiple sclerosis. A critical reappraisal
12. Viruses and MS
13. Viral etiology of multiple sclerosis: Where does the truth lie?
14. A putative new retrovirus associated with multiple sclerosis and the possible involvement of Epstein-Barr virus in this disease
15. Herpesvirus 6 might trigger multiple sclerosis
16. Expression of sequence variants of endogenous retrovirus RGH in particle form in multiple sclerosis
17. Viral infections trigger multiple sclerosis relapses - A prospective seroepidemiological study
18. Acyclovir treatment of relapsing-remitting multiple sclerosis. A randomized, placebo-controlled, double-blind study
19. Clinical viral infections and multiple sclerosis
20. Effects of influenza vaccination and influenza illness on exacerbations in multiple sclerosis
21. Analysis of the molecular basis of neuropathogenesis of RNA viruses in experimental animals: Relevance for human disease?
22. Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading
23. Adoptive transfer of EAE-like lesions from rats with corona-virus-induced demyelinating encephalomyelitis
24. Primarily chronic progressive and relapsing/remitting multiple sclerosis: Two immunologically distinct entities
25. Neuropathology in multiple sclerosis: New concepts
26. Distinct patterns of multiple sclerosis pathology indicates heterogeneity in pathogenesis
27. Experimental autoimmune encephalomyelitis: The antigen specificity of T lymphocytes determines the topography of lesions in the central and peripheral nervous system
28. Augmentation of demyelination in rat acute allergic encephalomyelitis by circulating mouse monoclonal antibodies directed against a myelin/oligodendrocyte glycoprotein
29. Anti-myelin antibodies modulate experimental allergic encephalomyelitis in Biozzi ABH mice
30. Identification of auto-antibodies associated with myelin damage in multiple sclerosis
31. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
32. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis
33. Adoptive transfer of EAE-like lesions from rats with corona-virus-induced demyelinating encephalomyelitis
34. Characterization of measles virus-induced autoimmune reactions against myelin basic protein in Lewis rats
35. Induction of autoimmune reactions to myelin basic protein in measles virus encephalitis in Lewis rats
36. Synergistic interaction between measles virus infection and myelin basic protein peptide-specific T cells in the induction of experimental allergic encephalomyelitis in Lewis rats
37. The balance between persistent virus infection and immune cells determines demyelination
38. Semliki Forest virus infection of mice: A model for the genetic and molecular analysis of viral pathogenicity
39. The molecular pathogenesis of Semliki Forest virus: A model virus made useful?
40. Immune responses, and autoimmune outcome, during virus infection of the central nervous system
41. Predisposition to EAE induction in resistant mice by prior infection with Semliki Forest virus
42. Production and role of cytokines in the CNS of mice with acute viral encephalomyelitis
43. Molecular mimicry between a viral peptide and a myelin oligodendrocyte glycoprotein peptide induces autoimmune demyelinating disease in mice
44. Long-term effects of Semliki Forest virus infection in the mouse central nervous system
45. Multiplication of virulent and demyelinating Semliki Forest virus in the mouse central nervous system - Consequences in BALB/c and SJL mice
46. Effect of viral infection on experimental allergic encephalomyelitis in mice
47. Facilitation of experimental allergic encephalomyelitis by irradiation and virus infection: Role of inflammatory cells
48. In vivo depletion of CD8+ T cells prevents lesions of demyelination in Semliki Forest virus infection
49. Role of immune responses in protection and pathogenesis during SFV infection
50. Characterization of the cellular and cytokine response in the central nervous system following Semliki Forest virus infection
51. Long-term persistence of activated cytotoxic T lymphocytes after viral infection of the central nervous system
52. Focal brain damage enhances experimental allergic encephalomyelitis in brain and spinal cord
53. Examination of eight cases of multiple sclerosis and 56 neurological and non-neurological controls for genome sequences of measles virus, canine distemper virus, simian virus 5 and rubella virus
54. Failure to detect measles virus RNA by reverse transcription-polymerase chain reaction, in peripheral blood leucocytes of patients with multiple sclerosis
55. Absence of measles, mumps and rubella viral gene sequences from multiple sclerosis brain tissue by polymerase chain reaction
56. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: A historical prospective study
57. B-cell responses to myelin basic protein and its epitopes in autoimmune encephalomyelitis induced by Semple rabies vaccine
58. A multicenter, randomized, double-blind placebo-controlled trial of influenza immunization in multiple sclerosis
59. Sequence homology between certain viral proteins and proteins related to encephalomyelitis and neuritis
60. Molecular mimicry in T-cell mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein
61. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity
62. Multiple sclerosis and molecular mimicry
63. Autoimmunity caused by host cell protein-containing viruses
64. Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis
65. Viral infection at the blood-brain barrier in multiple sclerosis: An ultrastructural study of tissues from a UK regional brain bank
66. Induction of relapsing paralysis in experimental autoimmune encephalomyelitis by bacterial superantigen
67. Reverse transcriptase-dependent and -independent phases of infection with mouse mammary tumor virus: Implications for superantigen function
68. The significance of measles virus antigen and genome distribution in the CNS in SSPE for mechanisms of viral spread and demyelination
69. Polyomavirus models of brain infection and the pathogenesis of multiple sclerosis
70. Semliki Forest virus neurovirulence mutants have altered cytopathogenicity for central nervous system cells
71. Oligodendrocyte infection and demyelination produced in mice by the M9 mutant of Semliki Forest virus
72. Pathogenicity of Semliki Forest virus for the rat central nervous system and primary rat neural cell cultures - Possible implications for the pathogenesis of multiple sclerosis
73. Death mechanisms in cultured cells infected by Semliki Forest virus
74. Morphology of oligodendrocytes during demyelination in optic nerves of mice infected with Semliki Forest virus
75. Antibody response to rubella virus structural proteins in multiple sclerosis
76. Multiplication of rubella and measles viruses in primary rat neural cell cultures: Relevance to a postulated triggering mechanism for multiple sclerosis
77. Oligodendroglial degeneration in distemper: Apoptosis or necrosis?
78. Aspects of canine distemper and measles virus encephalomyelitis
79. Measles encephalomyelitis - Clinical and immunologic studies
80. Multiple sclerosis and gamma interferon
81. Measles encephalomyelitis: Lack of evidence of viral invasion of the central nervous system and quantitative study of the nature of demyelination
82. Interferon beta-1b is effective in relapsing remitting multiple sclerosis
83. Interferon beta in the treatment of multiple sclerosis. Mechanism of action
84. Chemokines and chemokine receptors in CNS pathology
85. Encephalitis after hepatitis B vaccination - Recurrent disseminated encephalitis or MS?
86. No increase in demyelinating diseases after hepatitis B vaccination
87. Complications of mumps vaccines
88. Mumps component in combined measles, mumps and rubella vaccines
89. Peripheral neuropathy associated with anti-myelin basic protein antibodies in a woman vaccinated with rubella virus vaccine
90. Defending vaccines from the enemy within
91. DNA immunization
92. Exacerbation of viral and autoimmune animal models for multiple sclerosis by bacterial DNA
93. DNA vaccines with a kick
94. Vaccination with recombinant suicidal DNA/RNA
95. Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine
96. The Semliki Forest virus vector induces p53-independent apoptosis